SQZ Biotechnologies Company, focused on unlocking the full potential of cell therapies for multiple therapeutic areas, announced the publication of preclinical research on the SQZ Activating Antigen ...

WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies Company (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced the publication of ...